ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002

Capitol Hill: Sen. Harkin Introduces NIH Funding Bill That Boosts Budget to $46.2 Billion by 2021

July 25, 2014

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999

Ten Cooperative Group Chairs Propose Eight “Guiding Principles” For Change

May 20, 2011

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011